Trial Profile
A trial to evaluate the effects of dutasteride in combination with imidafenacin therapy in patients with benign prostate hyperplasia (BPH) who had large prostate volume (PV) and remaining overactive bladder (OAB) symptoms despite tamsulosin treatment
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Jun 2016
Price :
$35
*
At a glance
- Drugs Dutasteride (Primary) ; Imidafenacin (Primary)
- Indications Benign prostatic hyperplasia
- Focus Therapeutic Use
- 29 Jun 2016 New trial record